T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$2.6B |
| 2 |
BNY
Bank of New York Mellon
BNY
|
+$1.1B |
| 3 |
Elevance Health
ELV
|
+$903M |
| 4 |
DD
Du Pont De Nemours E I
DD
|
+$873M |
| 5 |
Medtronic
MDT
|
+$868M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$3.89B |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$1.06B |
| 3 |
CFN
CAREFUSION CORPORATION
CFN
|
+$946M |
| 4 |
Aptiv
APTV
|
+$886M |
| 5 |
KSU
Kansas City Southern
KSU
|
+$662M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.05% |
| 2 | Consumer Discretionary | 13.82% |
| 3 | Financials | 13.14% |
| 4 | Industrials | 11.9% |
| 5 | Technology | 9.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DATA
726
DELISTED
Tableau Software, Inc.
DATA
| $69.4M | 0.01% |
750,600
-31,567
| -4% | -$2.87M |
|
|
XXIA
727
DELISTED
Ixia
XXIA
| $69.3M | 0.01% |
5,710,390
+354,510
| +7% | +$3.93M |
|
728
Moog Inc Class A
MOG.A
$13.5B
| $69.2M | 0.01% |
921,537
+10,290
| +1% | +$760K |
|
729
QuidelOrtho
QDEL
$1.03B
| $68.6M | 0.01% |
2,543,140
-125,650
| -5% | -$3.21M |
|
|
BNCL
730
DELISTED
Beneficial Bancorp, Inc.
BNCL
| $68.5M | 0.01% |
6,068,371
+5,277,257
| +667% | +$58.5M |
|
|
CBF
731
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $68.4M | 0.01% |
2,477,820
+40,360
| +2% | +$1.05M |
|
732
Kimberly-Clark
KMB
$36.8B
| $68.2M | 0.01% |
636,915
+3,790
| +0.6% | +$419K |
|
733
Grupo Aval
AVAL
$6.35B
| $68.1M | 0.01% |
7,595,949
+1,214,979
| +19% | +$11.9M |
|
734
AZZ Inc
AZZ
$4.54B
| $68.1M | 0.01% |
1,461,779
-133,999
| -8% | -$5.9M |
|
735
Jazz Pharmaceuticals
JAZZ
$16B
| $68M | 0.01% |
393,700
-1,400
| -0.4% | -$240K |
|
|
NILE
736
DELISTED
Blue Nile, Inc.
NILE
| $68M | 0.01% |
2,136,459
+445,700
| +26% | +$14M |
|
737
CSX Corp
CSX
$93.8B
| $67.9M | 0.01% |
6,152,211
-57,720
| -0.9% | -$664K |
|
738
Burlington
BURL
$22.4B
| $67.9M | 0.01% |
1,142,298
+242,968
| +27% | +$13M |
|
739
Commerce Bancshares
CBSH
$8.62B
| $67.7M | 0.01% |
2,735,886
+404,196
| +17% | +$9.87M |
|
|
MNTA
740
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $67.1M | 0.01% |
4,417,686
+1,829,074
| +71% | +$23.8M |
|
|
GAP
741
The Gap Inc
GAP
$7.34B
| $66.7M | 0.01% |
1,538,318
+192,593
| +14% | +$8.03M |
|
|
STFC
742
DELISTED
State Auto Financial Corp
STFC
| $66.6M | 0.01% |
2,743,639
+305,086
| +13% | +$6.98M |
|
|
LPNT
743
DELISTED
LifePoint Health, Inc.
LPNT
| $66.6M | 0.01% |
907,227
-12,537
| -1% | -$890K |
|
|
NEWR
744
DELISTED
New Relic, Inc.
NEWR
| $66.1M | 0.01% |
1,981,304
+76,648
| +4% | +$2.59M |
|
|
ISEE
745
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $65.2M | 0.01% |
1,400,966
+30,924
| +2% | +$1.61M |
|
|
HOT
746
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $65.1M | 0.01% |
780,226
-5,575,022
| -88% | -$436M |
|
747
Adobe
ADBE
$105B
| $64.8M | 0.01% |
876,516
+19,710
| +2% | +$1.47M |
|
|
RLYP
748
DELISTED
RELYPSA INC COM
RLYP
| $64.5M | 0.01% |
1,789,149
+1,476,760
| +473% | +$53.3M |
|
|
BEE
749
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
| $64.4M | 0.01% |
5,182,582
+98,232
| +2% | +$1.29M |
|
750
Freeport-McMoran
FCX
$95.1B
| $64.1M | 0.01% |
3,383,580
-593,151
| -15% | -$11.7M |
|
Similar funds
T. Rowe Price Associates's Q1 2015 Portfolio in Review
As of Q1 2015, T. Rowe Price Associates held 2,630 positions worth $484B, up 2.8% from $471B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
T. Rowe Price Associates's Q1 2015 filing shows 93 new, 1,078 increased, 887 reduced and 93 closed positions. Its largest new stake was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M. The largest sale was Allergan Inc, an estimated $3.89B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q1 2015 buy was ACTAVIS PLC Pfd Conv Ser A (Irl): 516,600 shares worth $532M.
- T. Rowe Price Associates added most to Allergan plc in Q1 2015, an estimated $2.6B increase.
- T. Rowe Price Associates's biggest Q1 2015 reduction was Aptiv, cutting an estimated $886M.
- T. Rowe Price Associates fully exited Allergan Inc in Q1 2015, selling an estimated $3.89B.
- T. Rowe Price Associates's ten largest holdings make up 13% of its $484B portfolio in Q1 2015.
- T. Rowe Price Associates opened 93 new positions and closed 93 in Q1 2015.
- T. Rowe Price Associates's portfolio value rose 2.8% quarter-over-quarter to $484B.
Based on T. Rowe Price Associates's 13F filing for Q1 2015, filed 15 May 2015.